NIH-funded research NIH-funded research

Advanced multi-omic cancer profiling center

Official title: Center for Advanced Multi-Omic Characterization of Cancer

Funded at Battelle Pacific Northwest Laboratories · NIH-11323966 · Data updated 2026-11-12

A research center aims to deeply profile human tumors using multiple omics to better understand cancer and connect molecular findings with patient outcomes.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBattelle Pacific Northwest Laboratories
NIH-funded
Lab location1 site (Richland, United States)
Project startJune 1, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$1,240,013
NIH project number5U24CA271012-05
Project IDNIH-11323966 on NIH RePORTER

Who could benefit from this research

Could help

Patients whose tumor samples are collected and contributed to CPTAC/CPTAC-related studies may indirectly benefit from improved cancer understanding and future diagnostic advances.

Less likely to help

Direct patient benefit is not guaranteed; the grant primarily advances cancer biology and biomarker discovery.

What this research studies

This center plans to systematically characterize tumor samples from the National Cancer Institute and integrate proteomics, genomics, metabolomics, and other data to reveal how cancers differ at the molecular level. By adding acetylome and ubiquitinome analyses alongside phosphoproteomics, plus spatial and single-cell approaches, the project seeks a richer view of protein interactions, degradation, and signaling in cancer. The work continues CPTAC’s mission to provide high-quality, comprehensive data that can inform future diagnostics and treatments. Results should help clinicians and researchers identify new biomarkers and therapeutic targets.

Why it matters

Potential benefit: If successful, patients could benefit from improved cancer biomarkers and more precise targets for therapy.

How similar studies have gone: CPTAC has demonstrated success in comprehensive proteogenomic cancer profiling and data integration over the past decade.

Where this research is happening

  • Battelle Pacific Northwest Laboratories
    Richland, United States
    Active

Researchers

  • Principal investigator: Liu, Tao — Battelle Pacific Northwest Laboratories
  • Study coordinator: Liu, Tao

Related research

Other NIH-funded projects on the same topics.

  • Proteomics Center for MoTrPAC to map exercise effects in human tissues

    A research center is studying how physical activity changes proteins and their modifications in muscles and fat to understand exercise benefits for chronic diseases.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11516019

  • Islet cell pathways and regulators in early type 1 diabetes

    Researchers will study how insulin-producing beta cells deteriorate before type 1 diabetes becomes clinically apparent, using cutting-edge tissue analysis to find molecular clues that could lead to new therapies.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11457916

  • Protein targets of nitazenes and their metabolites in human cells

    Researchers will map which human brain, heart, and lung proteins interact with nitazene opioids, helping explain why these drugs can be so potent and dangerous.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11440279

  • High-throughput multiomic profiling of single cells

    A new platform will measure proteins, RNAs, and metabolites in thousands of individual human cells to better understand how cells regulate themselves.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11428734

  • Single-cell phospho-proteomics to map breast tumor microenvironment

    A researcher will develop a new, highly sensitive single-cell proteomics tool to map proteins and phosphorylation in breast cancer tumor environments, helping doctors tailor treatments.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11394417

  • High-Throughput Lipid Profiling with Precise Structures for Phenotypic Screening

    A project to develop advanced lipid profiling that can precisely identify lipid structures to help understand and screen diseases like Alzheimer's.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11386439

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.